Filing Details

Accession Number:
0000899243-20-014559
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-29 16:32:05
Reporting Period:
2020-05-27
Accepted Time:
2020-05-29 16:32:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1708493 Harpoon Therapeutics Inc. HARP () X0
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1700449 Plc Bioscience Arix 20 Berkeley Square
Mayfair, London X0 W1J 6EQ
No No Yes No
1756884 Ltd Holdings Bioscience Arix 20 Berkeley Square
Mayfair, London X0 W1J 6EQ
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-05-27 12,064 $22.39 2,560,295 No 4 S Indirect See Footnote
Common Stock Disposition 2020-05-28 366,591 $21.33 2,193,704 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $22.00 to $24.00 per share, inclusive. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission (the "SEC"), the Issuer, or a security holder of the Issuer.
  2. These shares are owned directly by Arix Bioscience Holdings Limited, which is a wholly owned subsidiary of Arix Bioscience Plc. Arix Bioscience Plc is an indirect beneficial owner of the reported securities and disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
  3. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $21.25 to $22.00 per share, inclusive. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.